Published in Arch Public Health on August 07, 2017
The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care (1992) 144.02
EuroQol--a new facility for the measurement of health-related quality of life. Health Policy (1990) 59.70
Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol (2003) 18.01
The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 13.01
Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ (1994) 10.96
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Qual Life Res (2011) 9.24
Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol (1998) 9.13
The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol (1982) 5.78
Lyme borreliosis. Lancet (2011) 4.81
Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 3.96
Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms. Int J Epidemiol (2005) 3.32
Subjective symptoms after treatment of early Lyme disease. Am J Med (2010) 3.22
Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets. Value Health (2012) 3.14
Long-term outcomes of persons with Lyme disease. JAMA (2000) 2.96
Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA (1996) 2.88
An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med (1995) 2.82
Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res (2012) 2.50
Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect (2011) 2.23
Lyme borreliosis in Europe. Euro Surveill (2011) 2.07
Ticks and associated pathogens collected from dogs and cats in Belgium. Parasit Vectors (2013) 1.93
Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Qual Life Res (2013) 1.67
Creating a coherent set of indicators to monitor health across Europe: the Euro-REVES 2 project. Eur J Public Health (2003) 1.62
Long-term follow-up of patients with culture-confirmed Lyme disease. Am J Med (2003) 1.62
Physician reported incidence of early and late Lyme borreliosis. Parasit Vectors (2015) 1.62
Prevalence of Neoehrlichia mikurensis in ticks and rodents from North-west Europe. Parasit Vectors (2012) 1.61
Chronic Lyme disease: a review. Infect Dis Clin North Am (2008) 1.46
DALY calculation in practice: a stepwise approach. Int J Public Health (2014) 1.32
Monitoring population disability: evaluation of a new Global Activity Limitation Indicator (GALI). Soz Praventivmed (2006) 1.30
Calculating disability-adjusted life years to quantify burden of disease. Int J Public Health (2014) 1.25
New methodology for estimating the burden of infectious diseases in Europe. PLoS Med (2012) 1.21
Chronic Lyme disease: the controversies and the science. Expert Rev Anti Infect Ther (2011) 1.17
Evaluating frequency, diagnostic quality, and cost of Lyme borreliosis testing in Germany: a retrospective model analysis. Clin Dev Immunol (2011) 1.08
Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009-2012. Ticks Tick Borne Dis (2014) 1.08
A prospective study among patients presenting at the general practitioner with a tick bite or erythema migrans in The Netherlands. PLoS One (2013) 1.05
Prospective study on the incidence of infection by Borrelia burgdorferi sensu lato after a tick bite in a highly endemic area of Switzerland. Ticks Tick Borne Dis (2011) 1.04
Epidemiological situation of Lyme borreliosis in Belgium, 2003 to 2012. Arch Public Health (2015) 0.98
Neuroborreliosis--an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden. Clin Microbiol Infect (2009) 0.97
Outcomes of treated human granulocytic ehrlichiosis cases. Emerg Infect Dis (2002) 0.97
Economic impact of Lyme disease. Emerg Infect Dis (2006) 0.96
Incidence and hospitalisation rates of Lyme borreliosis, France, 2004 to 2012. Euro Surveill (2014) 0.95
Health care costs, utilization and patterns of care following Lyme disease. PLoS One (2015) 0.95
Assessing the validity of the Global Activity Limitation Indicator in fourteen European countries. BMC Med Res Methodol (2015) 0.95
Lyme disease in France: a primary care-based prospective study. Epidemiol Infect (2005) 0.94
Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol (2015) 0.91
Development of a foundation for a case definition of post-treatment Lyme disease syndrome. Int J Infect Dis (2013) 0.91
Testing Dutch and French translations of the SF-36 Health Survey among Belgian angina patients. J Clin Epidemiol (1998) 0.90
Molecular Detection of Tick-Borne Pathogens in Humans with Tick Bites and Erythema Migrans, in the Netherlands. PLoS Negl Trop Dis (2016) 0.89
Chronic Lyme Disease and Co-infections: Differential Diagnosis. Open Neurol J (2012) 0.88
Incidence and management of presumption of Lyme borreliosis in Belgium: recent data from the sentinel network of general practitioners. Eur J Clin Microbiol Infect Dis (2012) 0.87
A social preference valuations set for EQ-5D health states in Flanders, Belgium. Eur J Health Econ (2009) 0.86
Coexposure to Borrelia burgdorferi and Babesia microti does not worsen the long-term outcome of lyme disease. Clin Infect Dis (2000) 0.85
Chronic coinfections in patients diagnosed with chronic lyme disease: a systematic review. Am J Med (2014) 0.85
Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011. PLoS One (2016) 0.83
The burden of Lyme borreliosis expressed in disability-adjusted life years. Eur J Public Health (2015) 0.83
Epidemiology and cost of hospital care for Lyme borreliosis in Germany: lessons from a health care utilization database analysis. Ticks Tick Borne Dis (2014) 0.83
Risk factors for a non-favorable outcome after treated European neuroborreliosis. Acta Neurol Scand (2012) 0.82
The Presence of Borrelia miyamotoi, A Relapsing Fever Spirochaete, in Questing Ixodes ricinus in Belgium and in The Netherlands. Zoonoses Public Health (2014) 0.82
A prospective study on the incidence of Borrelia burgdorferi sensu lato infection after a tick bite in Sweden and on the Åland Islands, Finland (2008-2009). Ticks Tick Borne Dis (2015) 0.82
Chronic Lyme disease. Infect Dis Clin North Am (2015) 0.82
Lyme disease--what is the cost for Scotland? Public Health (2003) 0.81
Relevance of chronic lyme disease to family medicine as a complex multidimensional chronic disease construct: a systematic review. Int J Family Med (2014) 0.78
Quality-of-life: a many-splendored thing? Belgian population norms and 34 potential determinants explored by beta regression. Qual Life Res (2017) 0.76
Posttreatment Lyme disease syndrome. Infect Dis Clin North Am (2015) 0.76
CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study. Clin Vaccine Immunol (2016) 0.75
Mapping EQ-5D utilities to GBD 2010 and GBD 2013 disability weights: results of two pilot studies in Belgium. Arch Public Health (2017) 0.75
Mathematical inference on helminth egg counts in stool and its applications in mass drug administration programmes to control soil-transmitted helminthiasis in public health. Adv Parasitol (2015) 0.89
Epidemiology, Impact and Control of Rabies in Nepal: A Systematic Review. PLoS Negl Trop Dis (2016) 0.86
Imbalanced presence of Borrelia burgdorferi s.l. multilocus sequence types in clinical manifestations of Lyme borreliosis. Infect Genet Evol (2016) 0.77
CystiSim - An Agent-Based Model for Taenia solium Transmission and Control. PLoS Negl Trop Dis (2016) 0.75
Inefficient co-feeding transmission of Borrelia afzelii in two common European songbirds. Sci Rep (2017) 0.75
Wealth-related inequality in early uptake of HIV testing among pregnant women: an analysis of data from a national cross-sectional survey, South Africa. BMJ Open (2017) 0.75
High relative humidity pre-harvest reduces post-harvest proliferation of Salmonella in tomatoes. Food Microbiol (2017) 0.75
Corrigendum to "Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy" [Eur J Cancer 67 (2016) 38-45]. Eur J Cancer (2017) 0.75
Melanoma burden by melanoma stage: Assessment through a disease transition model. Eur J Cancer (2015) 0.75
Clinical outbreak of babesiosis caused by Babesia capreoli in captive reindeer (Rangifer tarandus tarandus) in the Netherlands. Ticks Tick Borne Dis (2017) 0.75
Burden of salmonellosis, campylobacteriosis and listeriosis: a time series analysis, Belgium, 2012 to 2020. Euro Surveill (2017) 0.75
Cost-effectiveness analysis in melanoma detection: A transition model applied to dermoscopy. Eur J Cancer (2016) 0.75
Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure. Prev Med (2016) 0.75
A real-time assemblage-specific PCR assay for the detection of Giardia duodenalis assemblages A, B and E in fecal samples. Vet Parasitol (2015) 0.75